CRO services have gradually penetrated the healthcare sector in the past few years. With significant developments in the healthcare sector in terms of research, medications, drug delivery, etc., CROs are increasingly gaining prominence. As healthcare providers continue to recognize the benefits and advantages of consulting and opting for CRO services, the demand for such services is expected to grow at a significant pace during the forecast period (2019-2027). In the past few years, instead of outsourcing the entire project, biotech companies are leaning toward outsourcing part of clinical trials to CROs. In addition, stakeholders in the current contract research organization (CRO) services market are focusing their attention toward catering to niche and customized requirements of clinical trials.
In recent times, CRO services are assisting companies in the early phase development of new drugs and medications. Clinical research, consulting, and laboratory CRO services are increasingly being used by pharmaceutical companies, a factor expected to propel the growth of the contract research organization (CRO) services market during the assessment period. In addition, stakeholders involved in the current contract research organization (CRO) services market are expected to collaborate with each other to formulate open technology standards that are likely to revolutionize the future of clinical trial operations. Due to these factors and positive outlook of the healthcare sector, the global contract research organization (CRO) services market is expected to reach a value of ~US$ 96.4 Bn by 2027.
In the past decade, research and development in the pharmaceutical sector has experienced considerable increase. Established companies in the pharmaceutical sector are leaning toward leaner business models wherein dependence on external entities, such as CROs, is high. The significant growth of the biotech sector in the past decade has played an important role in resulting in rise in the number of companies involved in research and drug development. The exponential rise in the number of active and upcoming drug development companies and research projects created a huge window of opportunity for stakeholders involved in the contract research organization (CRO) services market. In the past decade, outsourcing of large or complex aspects of the drug development process has become imperative for the development of new drugs effectively and cost-effectively.
Although drug developers are increasingly leveraging CROs services, they are continually seeking solutions to address a host of challenges involved with this approach, such as high R&D cost, obtaining access and tracking the operations that are outsourced, and capacity constraints, among others. At present, stakeholders in the contract research organization (CRO) services market are increasingly adapting to the evolving research & development requirements and are expected to manage contracted work in several modalities. The number of outsourced projects in the last decade has transformed the overall structure of the drug development industry.
The lack of horizontal integration in the contract research organization (CRO) services market has largely been responsible for the inefficiencies in the operations and workflows. Furthermore, this has also isolated drug development processes, which has thus, encouraged the formulation of integrated CRO services models. The growing adoption of integrated model across the pharmaceutical sector has played an integral role in improving efficiency and minimizing the make-test cycle. While the horizontal integration model offered significant benefits and efficiencies in the drug development phase, its adoption in the U.S. was relatively slower than European countries such as the U.K. The demand for CROs services for early phase drug development and clinical research is expected to grow in the coming decade, due to a range of factors, including improved efficiency, streamlined management of R&D costs, low risk of repeat studies, accelerated drug development, and lowered operational costs, among others. Apart from offering monetary benefits, integrated contract organization services are likely to simply the supply chain and efficient management of clinical data.
Analysts’ Viewpoint
The global contract research organization (CRO) services market is expected to grow at an impressive CAGR of ~8% during the forecast period. The growth of the market can be largely attributed to significant rise in the number of drug development projects across the globe. Moreover, biotech and pharmaceutical companies are increasingly relying on CRO services to complete certain steps of the clinical development of drugs, which will create significant demand for CRO services during the forecast period. The outlook for the contract research organization (CRO) services market during the forecast period is positive, owing to the advent of integrated CRO models. Additionally, Stakeholders in the contract research organization (CRO) services market should focus on collaborating with pharmaceutical companies and leverage opportunities in North America and Europe– the two prominent regions in which large-scale drug development projects are being initiated.
Contract research organization (CRO) services market is expected to reach a value of ~US$ 96.4 Bn by 2027
Contract research organization (CRO) services market is projected to expand at a high CAGR of 8% during 2019 - 2027
Contract research organization (CRO) services market is driven by increase in the penetration of CROs, globalization of clinical trials
North America accounted for a major share of the global contract research organization (CRO) services market and the trend is anticipated to continue during the forecast period
Key players operating in the global contract research organization (CRO) services market are Laboratory Corporation of America Holdings, IQVIA Inc., Syneos Health, Inc., Parexel International Corporation, PRA Health Sciences
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Acronyms
3. Research Methodology
4. Executive Summary: Global Contract Research Organization (CRO) Services Market
5. Market Overview
5.1. Definition
5.2. Market Indicators
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunities
6. Market Outlook
6.1. Global Contract Research Organization (CRO) Services Market Revenue (US$ Mn) Forecast 2017–2027
6.2. Global Contract Research Organization (CRO) Services Market Outlook
6.3. Regulatory Scenario, by Region/Global
6.4. Clinical Trials Analysis
6.5. Key Mergers and Acquisitions
6.6. Heat Map Analysis
6.7. CROs - Business Model
6.8. CROs - Pricing Strategies
7. Global Contract Research Organization (CRO) Services Market Analysis and Forecast, by Service Type
7.1. Introduction
7.2. Global CRO Services Market Value Share Analysis, by Service Type
7.3. Global CRO Services Market Value Forecast, by Service Type, 2017–2027
7.3.1. Early Phase Development
7.3.1.1. Discovery Services
7.3.1.2. Chemistry
7.3.1.3. Preclinical Services
7.3.1.3.1. Toxicology
7.3.1.3.2. Pharmacokinetics
7.3.1.3.3. Others
7.3.2. Clinical Research Services
7.3.2.1. Phase I
7.3.2.2. Phase II
7.3.2.3. Phase III
7.3.2.4. Phase IV
7.3.3. Laboratory Services
7.3.3.1. Bioanalytical Services
7.3.3.2. Analytical Services
7.3.3.3. Others
7.3.4. Consulting Services
7.4. Global CRO Services Market Attractiveness, by Service Type
8. Global Contract Research Organization (CRO) Services Market Analysis and Forecast, by Therapeutic Indication
8.1. Introduction
8.2. Global CRO Services Market Value Share Analysis, by Therapeutic Indication
8.3. Global CRO Services Market Value Forecast, by Therapeutic Indication, 2017–2027
8.3.1. Oncology
8.3.2. Infectious Diseases
8.3.3. Immunological Disorders
8.3.4. Respiratory Diseases
8.3.5. Cardiovascular Diseases
8.3.6. Neurological Disorders
8.3.7. Others
8.4. Global CRO Services Market Attractiveness, by Therapeutic Indication
9. Global Contract Research Organization (CRO) Services Market Analysis and Forecast, by End-user
9.1. Introduction
9.2. Global CRO Services Market Value Share Analysis, by End-user
9.3. Global CRO Services Market Value Forecast, by End-user, 2017–2027
9.3.1. Medical Device Companies
9.3.2. Biopharmaceutical Companies
9.3.3. Others
9.4. Global CRO Services Market Attractiveness, by End-user
10. Global Contract Research Organization (CRO) Services Market Analysis and Forecast, by Region
10.1. Regional Outlook
10.2. Global Scenario
10.3. Introduction
10.4. Global Contract Research Organization (CRO) Services Market Value Forecast, by Region
10.4.1. North America
10.4.2. Europe
10.4.3. Asia Pacific
10.4.4. Latin America
10.4.5. Middle East & Africa
10.5. Global CRO Services Market Attractiveness, by Region
11. North America Contract Research Organization (CRO) Services Market Analysis and Forecast
11.1. Key Findings
11.2. North America Contract Research Organization (CRO) Services Market Value Forecast, by Service Type, 2017–2027
11.2.1. Early Phase Development
11.2.1.1. Discovery Services
11.2.1.2. Chemistry
11.2.1.3. Preclinical Services
11.2.1.3.1. Toxicology
11.2.1.3.2. Pharmacokinetics
11.2.1.3.3. Others
11.2.2. Clinical Research Services
11.2.2.1. Phase I
11.2.2.2. Phase II
11.2.2.3. Phase III
11.2.2.4. Phase IV
11.2.3. Laboratory Services
11.2.3.1. Bioanalytical Services
11.2.3.2. Analytical Services
11.2.3.3. Others
11.2.4. Consulting Services
11.3. North America Contract Research Organization (CRO) Services Market Value Forecast, by Therapeutic Indication, 2017–2027
11.3.1. Oncology
11.3.2. Infectious Diseases
11.3.3. Immunological Disorders
11.3.4. Respiratory Diseases
11.3.5. Cardiovascular Diseases
11.3.6. Neurological Disorders
11.3.7. Others
11.4. North America Contract Research Organization (CRO) Services Market Value Forecast, by End-user, 2017–2027
11.4.1. Medical Device Companies
11.4.2. Biopharmaceutical Companies
11.4.3. Others
11.5. North America Contract Research Organization (CRO) Services Market Value Forecast, by Country, 2017–2027
11.5.1. U.S.
11.5.2. Canada
11.6. North America Contract Research Organization (CRO) Services Market Attractiveness Analysis
11.6.1. By Service Type
11.6.2. By Therapeutic Indication
11.6.3. By End-user
11.6.4. By Country
12. Europe Contract Research Organization (CRO) Services Market Analysis and Forecast
12.1. Key Findings
12.2. Europe Contract Research Organization (CRO) Services Market Value Forecast, by Service Type, 2017–2027
12.2.1. Early Phase Development
12.2.1.1. Discovery Services
12.2.1.2. Chemistry
12.2.1.3. Preclinical Services
12.2.1.3.1. Toxicology
12.2.1.3.2. Pharmacokinetics
12.2.1.3.3. Others
12.2.2. Clinical Research Services
12.2.2.1. Phase I
12.2.2.2. Phase II
12.2.2.3. Phase III
12.2.2.4. Phase IV
12.2.3. Laboratory Services
12.2.3.1. Bioanalytical Services
12.2.3.2. Analytical Services
12.2.3.3. Others
12.2.4. Consulting Services
12.3. Europe Contract Research Organization (CRO) Services Market Value Forecast, by Therapeutic Indication, 2017–2027
12.3.1. Oncology
12.3.2. Infectious Diseases
12.3.3. Immunological Disorders
12.3.4. Respiratory Diseases
12.3.5. Cardiovascular Diseases
12.3.6. Neurological Disorders
12.3.7. Others
12.4. Europe Contract Research Organization (CRO) Services Market Value Forecast, by End-user, 2017–2027
12.4.1. Medical Device Companies
12.4.2. Biopharmaceutical Companies
12.4.3. Others
12.5. Europe Contract Research Organization (CRO) Services Market Value Forecast, by Country/Sub-region, 2017–2027
12.5.1. U.K.
12.5.2. Germany
12.5.3. France
12.5.4. Italy
12.5.5. Spain
12.5.6. Rest of Europe
12.6. Europe Contract Research Organization (CRO) Services Market Attractiveness Analysis
12.6.1. By Service Type
12.6.2. By Therapeutic Indication
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Asia Pacific Contract Research Organization (CRO) Services Market Analysis and Forecast
13.1. Key Findings
13.2. Asia Pacific Contract Research Organization (CRO) Services Market Value Forecast, by Service Type, 2017–2027
13.2.1. Early Phase Development
13.2.1.1. Discovery Services
13.2.1.2. Chemistry
13.2.1.3. Preclinical Services
13.2.1.3.1. Toxicology
13.2.1.3.2. Pharmacokinetics
13.2.1.3.3. Others
13.2.2. Clinical Research Services
13.2.2.1. Phase I
13.2.2.2. Phase II
13.2.2.3. Phase III
13.2.2.4. Phase IV
13.2.3. Laboratory Services
13.2.3.1. Bioanalytical Services
13.2.3.2. Analytical Services
13.2.3.3. Others
13.2.4. Consulting Services
13.3. Asia Pacific Contract Research Organization (CRO) Services Market Value Forecast, by Therapeutic Indication, 2017–2027
13.3.1. Oncology
13.3.2. Infectious Diseases
13.3.3. Immunological Disorders
13.3.4. Respiratory Diseases
13.3.5. Cardiovascular Diseases
13.3.6. Neurological Disorders
13.3.7. Others
13.4. Asia Pacific Contract Research Organization (CRO) Services Market Value Forecast, by End-user, 2017–2027
13.4.1. Medical Device Companies
13.4.2. Biopharmaceutical Companies
13.4.3. Others
13.5. Asia Pacific Contract Research Organization (CRO) Services Market Value Forecast, by Country/Sub-region, 2017–2027
13.5.1. China
13.5.2. India
13.5.3. Japan
13.5.4. Australia & New Zealand
13.5.5. Rest of Asia Pacific
13.6. Asia Pacific Contract Research Organization (CRO) Services Market Attractiveness Analysis
13.6.1. By Service Type
13.6.2. By Therapeutic Indication
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Latin America Contract Research Organization (CRO) Services Market Analysis and Forecast
14.1. Key Findings
14.2. Latin America Contract Research Organization (CRO) Services Market Value Forecast, by Service Type, 2017–2027
14.2.1. Early Phase Development
14.2.1.1. Discovery Services
14.2.1.2. Chemistry
14.2.1.3. Preclinical Services
14.2.1.3.1. Toxicology
14.2.1.3.2. Pharmacokinetics
14.2.1.3.3. Others
14.2.2. Clinical Research Services
14.2.2.1. Phase I
14.2.2.2. Phase II
14.2.2.3. Phase III
14.2.2.4. Phase IV
14.2.3. Laboratory Services
14.2.3.1. Bioanalytical Services
14.2.3.2. Analytical Services
14.2.3.3. Others
14.2.4. Consulting Services
14.3. Latin America Contract Research Organization (CRO) Services Market Value Forecast, by Therapeutic Indication, 2017–2027
14.3.1. Oncology
14.3.2. Infectious Diseases
14.3.3. Immunological Disorders
14.3.4. Respiratory Diseases
14.3.5. Cardiovascular Diseases
14.3.6. Neurological Disorders
14.3.7. Others
14.4. Latin America Contract Research Organization (CRO) Services Market Value Forecast, by End-user, 2017–2027
14.4.1. Medical Device Companies
14.4.2. Biopharmaceutical Companies
14.4.3. Others
14.5. Latin America Contract Research Organization (CRO) Services Market Value Forecast, by Country/Sub-region, 2017–2027
14.5.1. Brazil
14.5.2. Mexico
14.5.3. Rest of Latin America
14.6. Latin America Contract Research Organization (CRO) Services Market Attractiveness Analysis
14.6.1. By Service
14.6.2. By Therapeutic Indication
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Middle East & Africa Contract Research Organization (CRO) Services Market Analysis and Forecast
15.1. Key Findings
15.2. Middle East & Africa Contract Research Organization (CRO) Services Market Value Forecast, by Service Type, 2017–2027
15.2.1. Early Phase Development
15.2.1.1. Discovery Services
15.2.1.2. Chemistry
15.2.1.3. Preclinical Services
15.2.1.3.1. Toxicology
15.2.1.3.2. Pharmacokinetics
15.2.1.3.3. Others
15.2.2. Clinical Research Services
15.2.2.1. Phase I
15.2.2.2. Phase II
15.2.2.3. Phase III
15.2.2.4. Phase IV
15.2.3. Laboratory Services
15.2.3.1. Bioanalytical Services
15.2.3.2. Analytical Services
15.2.3.3. Others
15.2.4. Consulting Services
15.3. Middle East & Africa Contract Research Organization (CRO) Services Market Value Forecast, by Therapeutic Indication, 2017–2027
15.3.1. Oncology
15.3.2. Infectious Diseases
15.3.3. Immunological Disorders
15.3.4. Respiratory Diseases
15.3.5. Cardiovascular Diseases
15.3.6. Neurological Disorders
15.3.7. Others
15.4. Middle East & Africa Contract Research Organization (CRO) Services Market Value Forecast, by End-user, 2017–2027
15.4.1. Medical Device Companies
15.4.2. Biopharmaceutical Companies
15.4.3. Others
15.5. Middle East & Africa Contract Research Organization (CRO) Services Market Value Forecast, by Country/Sub-region, 2017–2027
15.5.1. GCC
15.5.2. South Africa
15.5.3. Rest of Middle East & Africa
15.6. Middle East & Africa Contract Research Organization (CRO) Services Market Attractiveness Analysis
15.6.1. By Service
15.6.2. By Therapeutic Indication
15.6.3. By End-user
15.6.4. By Country/Sub-region
16. Competition Landscape
16.1. Competition Matrix
16.2. Global CRO Services Market Share Analysis, by Company, 2018
16.3. Company Profiles
16.3.1. Laboratory Corporation of America Holdings
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Financial Overview
16.3.1.3. Product Portfolio
16.3.1.4. Strategic Overview
16.3.1.5. SWOT Analysis
16.3.2. IQVIA Inc.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Financial Overview
16.3.2.3. Product Portfolio
16.3.2.4. Strategic Overview
16.3.2.5. SWOT Analysis
16.3.3. Syneos Health, Inc.
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Financial Overview
16.3.3.3. Product Portfolio
16.3.3.4. Strategic Overview
16.3.3.5. SWOT Analysis
16.3.4. Parexel International Corporation
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Financial Overview
16.3.4.3. Product Portfolio
16.3.4.4. Strategic Overview
16.3.4.5. SWOT Analysis
16.3.5. PRA Health Sciences, Inc.
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Financial Overview
16.3.5.3. Product Portfolio
16.3.5.4. Strategic Overview
16.3.5.5. SWOT Analysis
16.3.6. PPD, Inc.
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Financial Overview
16.3.6.3. Product Portfolio
16.3.6.4. Strategic Overview
16.3.6.5. SWOT Analysis
16.3.7. Charles River Laboratories, Inc.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Financial Overview
16.3.7.3. Product Portfolio
16.3.7.4. Strategic Overview
16.3.7.5. SWOT Analysis
16.3.8. Icon plc
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Financial Overview
16.3.8.3. Product Portfolio
16.3.8.4. Strategic Overview
16.3.8.5. SWOT Analysis
16.3.9. WuXi AppTec Group
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Financial Overview
16.3.9.3. Product Portfolio
16.3.9.4. Strategic Overview
16.3.9.5. SWOT Analysis
16.3.10. Medpace
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Financial Overview
16.3.10.3. Product Portfolio
16.3.10.4. Strategic Overview
16.3.10.5. SWOT Analysis
List of Tables
Table 01: CROs - Heat Map Analysis
Table 02: CROs – Business Models
Table 03: Global CRO Services Market Value (US$ Mn) Forecast, by Service Type, 2017–2027
Table 04: Global CRO Services Market Value (US$ Mn) Forecast, by Early Phase Development, 2017–2027
Table 05: Global CRO Services Market Value (US$ Mn) Forecast, by Preclinical Services, 2017–2027
Table 06: Global CRO Services Market Value (US$ Mn) Forecast, by Clinical Research Services, 2017–2027
Table 07: Global CRO Services Market Value (US$ Mn) Forecast, by Laboratory Services, 2017–2027
Table 08: Global CRO Services Market Value (US$ Mn) Forecast, by Therapeutic Indication, 2017–2027
Table 09: Global CRO Services Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 10: Global CRO Services Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 11: North America CRO Services Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 12: North America CRO Services Market Value (US$ Mn) Forecast, by Service Type, 2017–2027
Table 13: North America CRO Services Market Value (US$ Mn) Forecast, by Early Phase Development, 2017–2027
Table 14: North America CRO Services Market Value (US$ Mn) Forecast, by Preclinical Services, 2017–2027
Table 15: North America CRO Services Market Value (US$ Mn) Forecast, by Clinical Research Services, 2017–2027
Table 16: North America CRO Services Market Value (US$ Mn) Forecast, by Laboratory Services, 2017–2027
Table 17: North America CRO Services Market Value (US$ Mn) Forecast, by Therapeutic Indication, 2017–2027
Table 18: North America CRO Services Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 19: Europe CRO Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 20: Europe CRO Services Market Value (US$ Mn) Forecast, by Service Type, 2017–2027
Table 21: Europe CRO Services Market Value (US$ Mn) Forecast, by Early Phase Development, 2017–2027
Table 22: Europe CRO Services Market Value (US$ Mn) Forecast, by Preclinical Services, 2017–2027
Table 23: Europe CRO Services Market Value (US$ Mn) Forecast, by Clinical Research Services, 2017–2027
Table 24: Europe CRO Services Market Value (US$ Mn) Forecast, by Laboratory Services, 2017–2027
Table 25: Europe CRO Services Market Value (US$ Mn) Forecast, by Therapeutic Indication, 2017–2027
Table 26: Europe CRO Services Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 27: Asia Pacific CRO Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 28: Asia Pacific CRO Services Market Value (US$ Mn) Forecast, by Service Type, 2017–2027
Table 29: Asia Pacific CRO Services Market Value (US$ Mn) Forecast, by Early Phase Development, 2017–2027
Table 30: Asia Pacific CRO Services Market Value (US$ Mn) Forecast, by Preclinical Services, 2017–2027
Table 31: Asia Pacific CRO Services Market Value (US$ Mn) Forecast, by Clinical Research Services, 2017–2027
Table 32: Asia Pacific CRO Services Market Value (US$ Mn) Forecast, by Laboratory Services, 2017–2027
Table 33: Asia Pacific CRO Services Market Value (US$ Mn) Forecast, by Therapeutic Indication, 2017–2027
Table 34: Asia Pacific CRO Services Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 35: Latin America CRO Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 36: Latin America CRO Services Market Value (US$ Mn) Forecast, by Service Type, 2017–2027
Table 37: Latin America CRO Services Market Value (US$ Mn) Forecast, by Early Phase Development, 2017–2027
Table 38: Latin America CRO Services Market Value (US$ Mn) Forecast, by Preclinical Services, 2017–2027
Table 39: Latin America CRO Services Market Value (US$ Mn) Forecast, by Clinical Research Services, 2017–2027
Table 40: Latin America CRO Services Market Value (US$ Mn) Forecast, by Laboratory Services, 2017–2027
Table 41: Latin America CRO Services Market Value (US$ Mn) Forecast, by Therapeutic Indication, 2017–2027
Table 42: Latin America CRO Services Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 43: Middle East & Africa CRO Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 44: Middle East & Africa CRO Services Market Value (US$ Mn) Forecast, by Service Type, 2017–2027
Table 45: Middle East & Africa CRO Services Market Value (US$ Mn) Forecast, by Early Phase Development, 2017–2027
Table 46: Middle East & Africa CRO Services Market Value (US$ Mn) Forecast, by Preclinical Services, 2017–2027
Table 47: Middle East & Africa CRO Services Market Value (US$ Mn) Forecast, by Clinical Research Services, 2017–2027
Table 48: Middle East & Africa CRO Services Market Value (US$ Mn) Forecast, by Laboratory Services, 2017–2027
Table 49: Middle East & Africa CRO Services Market Value (US$ Mn) Forecast, by Therapeutic Indication, 2017–2027
Table 50: Middle East & Africa CRO Services Market Value (US$ Mn) Forecast, by End-user, 2017–2027
List of Figures
Figure 01: Global Contract Research Organization (CRO) Services Market Snapshot
Figure 02: Global Contract Research Organization (CRO) Services Market Value (US$ Mn), by Region, 2019 and 2027
Figure 03: Penetration of Clinical CRO Outsourcing Services
Figure 04: Increase in Clinical Trials
Figure 05: Global CRO Services Market Value (US$ Mn) Forecast, 2017–2027
Figure 06: Global CRO Services Market Value Share (%), by Service Type (2019)
Figure 07: Global CRO Services Market Value Share (%), by Therapeutic Indication (2019)
Figure 08: Global CRO Services Market Value Share (%), by End-user (2019)
Figure 09: Global CRO Services Market Value Share (%), by Region (2019)
Figure 10: Regulatory Scenario – North America
Figure 11: Regulatory Scenario – Europe
Figure 12: Regulatory Scenario – Asia Pacific
Figure 13: Number of Registered Studies, by Location
Figure 14: Number of Registered Studies, by Intervention
Figure 15: Global CRO Services Market – Key Mergers and Acquisitions
Figure 16: CROs- Pricing Strategies
Figure 17: Key Strategies – Laboratory Corporation of America Holdings (LabCorp)
Figure 18: Key Strategies – IQVIA
Figure 19: Global CRO Services Market Value Share Analysis, by Service Type, 2018 and 2027
Figure 20: Global CRO Services Market Attractiveness, by Service Type, 2019?2027
Figure 21: Global CRO Services Market Value Share Analysis, by Early Phase Development, 2018 and 2027
Figure 22: Global CRO Services Market Attractiveness, by Early Phase Development, 2019?2027
Figure 23: Global CRO Services Market Value Share Analysis, by Preclinical Services, 2018 and 2027
Figure 24: Global CRO Services Market Attractiveness, by Preclinical Services, 2019?2027
Figure 25: Global CRO Services Market Value Share Analysis, by Clinical Research Services, 2018 and 2027
Figure 26: Global CRO Services Market Attractiveness, by Clinical Research Services, 2019?2027
Figure 27: Global CRO Services Market Value Share Analysis, by Laboratory Services, 2018 and 2027
Figure 28: Global CRO Services Market Attractiveness, by Laboratory Services, 2019?2027
Figure 29: Global CRO Services Market Value (US$ Mn) Forecast, by Early Phase Development, 2017–2027
Figure 30: Global CRO Services Market Value (US$ Mn) Forecast, by Clinical Research Services, 2017–2027
Figure 31: Global CRO Services Market Value (US$ Mn) Forecast, by Laboratory Services, 2017–2027
Figure 32: Global CRO Services Market Value (US$ Mn) Forecast, by Consulting Services, 2017–2027
Figure 33: Global CRO Services Market Value (US$ Mn) Forecast, by Discovery Services, 2017–2027
Figure 34: Global CRO Services Market Value (US$ Mn) Forecast, by Chemistry, 2017–2027
Figure 35: Global CRO Services Market Value (US$ Mn) Forecast, by Preclinical Services, 2017–2027
Figure 36: Global CRO Services Market Value (US$ Mn) Forecast, by Phase I, 2017–2027
Figure 37: Global CRO Services Market Value (US$ Mn) Forecast, by Phase II, 2017–2027
Figure 38: Global CRO Services Market Value (US$ Mn) Forecast, by Phase III, 2017–2027
Figure 39: Global CRO Services Market Value (US$ Mn) Forecast, by Phase IV, 2017–2027
Figure 40: Global CRO Services Market Value (US$ Mn) Forecast, by Bio-analytical services, 2017–2027
Figure 41: Global CRO Services Market Value (US$ Mn) Forecast, by Analytical Services, 2017–2027
Figure 42: Global CRO Services Market Value (US$ Mn) Forecast, by Others, 2017–2027
Figure 43: Global CRO Services Market Value Share Analysis, by Therapeutic Indication, 2018 and 2027
Figure 44: Global CRO Services Market Value (US$ Mn) Forecast, by Oncology, 2017–2027
Figure 45: Global CRO Services Market Value (US$ Mn) Forecast, by Infectious Diseases, 2017–2027
Figure 46: Global CRO Services Market Value (US$ Mn) Forecast, by Immunological Disorders, 2017–2027
Figure 47: Global CRO Services Market Value (US$ Mn) Forecast, by Respiratory Diseases, 2017–2027
Figure 48: Global CRO Services Market Value (US$ Mn) Forecast, by Cardiovascular Diseases, 2017–2027
Figure 49: Global CRO Services Market Value (US$ Mn) Forecast, by Neurological Disorders, 2017–2027
Figure 50: Global CRO Services Market Value (US$ Mn) Forecast, by Others, 2017–2027
Figure 51: Global CRO Services Market Attractiveness, by Therapeutic Indication, 2019?2027
Figure 52: Global CRO Services Market Value Share Analysis, by End-user, 2018 and 2027
Figure 53: Global CRO Services Market Value (US$ Mn) Forecast, by Medical Device Companies , 2017–2027
Figure 54: Global CRO Services Market Value (US$ Mn) Forecast, by Biopharmaceutical Companies, 2017–2027
Figure 55: Global CRO Services Market Value (US$ Mn) Forecast, by Others, 2017–2027
Figure 56: Global CRO Services Market Attractiveness, by End-user, 2019?2027
Figure 57: Global CRO Services Market: Regional Outlook
Figure 58: Global CRO Services Market Value (US$ Mn) Forecast, 2017–2027
Figure 59: Global CRO Services Market Value Share Analysis, by Region, 2018 and 2027
Figure 60: Global CRO Services Market Attractiveness, by Region, 2019?2027
Figure 61: North America CRO Services Market Value (US$ Mn) Forecast, 2017–2027
Figure 62: North America CRO Services Market Attractiveness Analysis, by Country, 2019–2027
Figure 63: North America CRO Services Market Value Share Analysis, by Country, 2018 and 2027
Figure 64: North America CRO Services Market Value Share Analysis, by Service Type, 2018 and 2027
Figure 65: North America CRO Services Market Value Share Analysis, by Early Phase Development, 2018 and 2027
Figure 66: North America CRO Services Market Value Share Analysis, by Clinical Research Services, 2018 and 2027
Figure 67: North America CRO Services Market Value Share Analysis, by Laboratory Services, 2018 and 2027
Figure 68: North America CRO Services Market Value Share Analysis, by Therapeutic Indication, 2018 and 2027
Figure 69: North America CRO Services Market Value Share Analysis, by End-user, 2018 and 2027
Figure 70: North America CRO Services Market Attractiveness, by Service Type, 2019?2027
Figure 71: North America CRO Services Market Attractiveness, by Early Phase Development, 2019?2027
Figure 72: North America CRO Services Market Attractiveness, by Clinical Research Services, 2019?2027
Figure 73: North America CRO Services Market Attractiveness, by Laboratory Services, 2019?2027
Figure 74: North America CRO Services Market Attractiveness, by Therapeutic Indication, 2019?2027
Figure 75: North America CRO Services Market Attractiveness, by End-user, 2019?2027
Figure 76: Europe CRO Services Market Value (US$ Mn) Forecast, 2017–2027
Figure 77: Europe CRO Services Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 78: Europe CRO Services Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 79: Europe CRO Services Market Value Share Analysis, by Service Type, 2018 and 2027
Figure 80: Europe CRO Services Market Value Share Analysis, by Early Phase Development, 2018 and 2027
Figure 81: Europe CRO Services Market Value Share Analysis, by Clinical Research Services, 2018 and 2027
Figure 82: Europe CRO Services Market Value Share Analysis, by Laboratory Services, 2018 and 2027
Figure 83: Europe CRO Services Market Value Share Analysis, by Therapeutic Indication, 2018 and 2027
Figure 84: Europe CRO Services Market Value Share Analysis, by End-user, 2018 and 2027
Figure 85: Europe CRO Services Market Attractiveness, by Service Type, 2019?2027
Figure 86: Europe CRO Services Market Attractiveness, by Early Phase Development, 2019?2027
Figure 87: Europe CRO Services Market Attractiveness, by Clinical Research Services, 2019?2027
Figure 88: Europe CRO Services Market Attractiveness, by Laboratory Services, 2019?2027
Figure 89: Europe CRO Services Market Attractiveness, by Therapeutic Indication, 2019?2027
Figure 90: Europe CRO Services Market Attractiveness, by End-user, 2019?2027
Figure 91: Asia Pacific CRO Services Market Value (US$ Mn) Forecast, 2017–2027
Figure 92: Asia Pacific CRO Services Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 93: Asia Pacific CRO Services Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 94: Asia Pacific CRO Services Market Value Share Analysis, by Service Type, 2018 and 2027
Figure 95: Asia Pacific CRO Services Market Value Share Analysis, by Early Phase Development, 2018 and 2027
Figure 96: Asia Pacific CRO Services Market Value Share Analysis, by Clinical Research Services, 2018 and 2027
Figure 97: Asia Pacific CRO Services Market Value Share Analysis, by Laboratory Services, 2018 and 2027
Figure 98: Asia Pacific CRO Services Market Value Share Analysis, by Therapeutic Indication, 2018 and 2027
Figure 99: Asia Pacific CRO Services Market Value Share Analysis, by End-user, 2018 and 2027
Figure 100: Asia Pacific CRO Services Market Attractiveness, by Service Type, 2019?2027
Figure 101: Asia Pacific CRO Services Market Attractiveness, by Early Phase Development, 2019?2027
Figure 102: Asia Pacific CRO Services Market Attractiveness, by Clinical Research Services, 2019?2027
Figure 103: Asia Pacific CRO Services Market Attractiveness, by Laboratory Services, 2019?2027
Figure 104: Asia Pacific CRO Services Market Attractiveness, by Therapeutic Indication, 2019?2027
Figure 105: Asia Pacific CRO Services Market Attractiveness, by End-user, 2019?2027
Figure 106: Latin America CRO Services Market Value (US$ Mn) Forecast, 2017–2027
Figure 107: Latin America CRO Services Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 108: Latin America CRO Services Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 109: Latin America CRO Services Market Value Share Analysis, by Service Type, 2018 and 2027
Figure 110: Latin America CRO Services Market Value Share Analysis, by Early Phase Development, 2018 and 2027
Figure 111: Latin America CRO Services Market Value Share Analysis, by Clinical Research Services, 2018 and 2027
Figure 112: Latin America CRO Services Market Value Share Analysis, by Laboratory Services, 2018 and 2027
Figure 113: Latin America CRO Services Market Value Share Analysis, by Therapeutic Indication, 2018 and 2027
Figure 114: Latin America CRO Services Market Value Share Analysis, by End-user, 2018 and 2027
Figure 115: Latin America CRO Services Market Attractiveness, by Service Type, 2019?2027
Figure 116: Latin America CRO Services Market Attractiveness, by Early Phase Development, 2019?2027
Figure 117: Latin America CRO Services Market Attractiveness, by Clinical Research Services, 2019?2027
Figure 118: Latin America CRO Services Market Attractiveness, by Laboratory Services, 2019?2027
Figure 119: Latin America CRO Services Market Attractiveness, by Therapeutic Indication, 2019?2027
Figure 120: Latin America CRO Services Market Attractiveness, by End-user, 2019?2027
Figure 121: Middle East & Africa CRO Services Market Value (US$ Mn) Forecast, 2017–2027
Figure 122: Middle East & Africa CRO Services Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 123: Middle East & Africa CRO Services Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 124: Middle East & Africa CRO Services Market Value Share Analysis, by Service Type, 2018 and 2027
Figure 125: Middle East & Africa CRO Services Market Value Share Analysis, by Early Phase Development, 2018 and 2027
Figure 126: Middle East & Africa CRO Services Market Value Share Analysis, by Clinical Research Services, 2018 and 2027
Figure 127: Middle East & Africa CRO Services Market Value Share Analysis, by Laboratory Services, 2018 and 2027
Figure 128: Middle East & Africa CRO Services Market Value Share Analysis, by Therapeutic Indication, 2018 and 2027
Figure 129: Middle East & Africa CRO Services Market Value Share Analysis, by End-user, 2018 and 2027
Figure 130: Middle East & Africa CRO Services Market Attractiveness, by Service Type, 2019?2027
Figure 131: Middle East & Africa CRO Services Market Attractiveness, by Early Phase Development, 2019?2027
Figure 132: Middle East & Africa CRO Services Market Attractiveness, by Clinical Research Services, 2019?2027
Figure 133: Middle East & Africa CRO Services Market Attractiveness, by Laboratory Services, 2019?2027
Figure 134: Middle East & Africa CRO Services Market Attractiveness, by Therapeutic Indication, 2019?2027
Figure 135: Middle East & Africa CRO Services Market Attractiveness, by End-user, 2019?2027
Figure 136: Global CRO Services Market Share, by Company, 2018
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Contract Research Organization (CRO) Services Market
